EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of the COVID‐19 Outbreak on the Incidence of Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes Associated Antibodies in Singapore

Rui Ling Rena Lau, Karine Su Shan Tay, Seyed Ehsan Saffari, Patricia Yut Wan Wong, Mei Ting Lim, Angelia Swee Hoon Koe, Jeanne May May Tan, Kok Pin Yong, Kevin Tan iD, Josiah Yui Huei Chai, Tianrong Yeo iD

Brain and Behavior · 2025

DOI: 10.1002/brb3.70630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Rui Ling Rena Lau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Duke-NUS Medical School, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: COVID-19, Hashimoto Disease, Paraneoplastic Syndromes, Nervous System, Autoantibodies. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging evidence suggests a potential association between COVID‐19 and autoimmune encephalitis (AE). We aimed to evaluate the positivity rate of AE‐ and paraneoplastic neurological syndromes (PNS)‐associated antibodies in relation to COVID‐19.

Methods

We investigated the frequency and incidence of AE‐ and PNS‐associated antibodies amongst clinical tests performed at the National Neuroscience Institute, Singapore, before and during the COVID‐19 pandemic. Antibodies against surface‐exposed antigens associated with AE were tested using cell‐based assays; antibodies against intracellular antigens in PNS were detected by immunoblot and tissue‐based assays.

Results

A total of 87 of 4347 samples and 29 of 3393 samples tested for AE‐ and PNS‐associated antibodies, respectively, were positive. A spike in the incidence of AE‐associated antibodies was observed in 2020 at 4.92 (95% CI, 3.05–7.53) per 1,000,000 person‐years, coinciding with the first year of the COVID‐19 “pandemic outbreak.” The cumulative incidence in the “pre‐pandemic” period from 2017 to 2019 was 2.44 (95% CI, 1.66–3.46) per 1,000,000 person‐years ( p = 0.034, vs. “pandemic outbreak”), and in the “mid to late pandemic” period from 2021 to 2023, this was 2.74 (95% CI, 1.91–3.82) per 1,000,000 person‐years ( p = 0.086, vs. “pandemic outbreak”). The incidence of PNS‐associated antibodies was unaffected by the COVID‐19 pandemic.

Conclusions

The increased incidence of AE‐associated antibodies during the COVID‐19 “pandemic outbreak” suggests a potential biological link. The subsequent decline in incidence in the “mid to late pandemic” period may be attributable to widespread vaccination and the emergence of new viral variants with less potential to induce autoimmunity. The incidence of PNS‐associated antibodies was stable throughout, reinforcing its primary association with malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hashimoto DiseaseParaneoplastic Syndromes, Nervous SystemAutoantibodiesEncephalitisHumansSingaporeIncidenceMaleFemaleMiddle AgedAdultAgedSARS-CoV-2Young Adult

Stichwörter der Autor:innen

COVID‐19antibodiesautoimmune encephalitisincidenceparaneoplastic neurological syndrome

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Duke-NUS Medical School, National University of Singapore, Singapore, Singapore.
  • Neuromuscular Laboratory, National Neuroscience Institute, Singapore, Singapore.
  • Department of Neurology (Tan Tock Seng Hospital Campus), National Neuroscience Institute, Singapore, Singapore.
  • Department of Neurology (Singapore General Hospital Campus), National Neuroscience Institute, Singapore, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

ORCID-Profile: Kevin Tan, Tianrong Yeo

Zitieren

APA

Lau, R. L. R., Tay, K. S. S., Saffari, S. E., Wong, P. Y. W., Lim, M. T., Koe, A. S. H., Tan, J. M. M., Yong, K. P., Tan, K., Chai, J. Y. H., & Yeo, T. (2025). Impact of the COVID‐19 Outbreak on the Incidence of Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes Associated Antibodies in Singapore. Brain and Behavior. https://doi.org/10.1002/brb3.70630

Vancouver

Lau RLR, Tay KSS, Saffari SE, Wong PYW, Lim MT, Koe ASH, et al. Impact of the COVID‐19 Outbreak on the Incidence of Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes Associated Antibodies in Singapore. Brain and Behavior. 2025. doi:10.1002/brb3.70630

BibTeX
@article{Lau2025,
  author = {Lau, Rui Ling Rena and Tay, Karine Su Shan and Saffari, Seyed Ehsan and Wong, Patricia Yut Wan and Lim, Mei Ting and Koe, Angelia Swee Hoon and Tan, Jeanne May May and Yong, Kok Pin and Tan, Kevin and Chai, Josiah Yui Huei and Yeo, Tianrong},
  title = {Impact of the COVID‐19 Outbreak on the Incidence of Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes Associated Antibodies in Singapore},
  journal = {Brain and Behavior},
  year = {2025},
  doi = {10.1002/brb3.70630}
}
Kostenlos starten →